Singapore markets closed

bioAffinity Technologies, Inc. (BIAF)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.0200-0.0500 (-2.42%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
2,532
2,532
4.803
0
0
Cost of revenue
1,741
1,741
0.467
0
-
Gross profit
791.615
791.615
4.336
0
-
Operating expenses
Research development
1,725
1,725
1,524
1,138
1,610
Selling general and administrative
6,791
6,791
2,481
1,069
994.343
Total operating expenses
8,765
8,765
4,015
2,207
2,604
Operating income or loss
-7,973
-7,973
-4,011
-2,207
-2,604
Interest expense
37.125
37.125
2,533
1,002
382.171
Total other income/expenses net
-27.796
-27.796
-1,655
-3,116
-4,281
Income before tax
-7,916
-7,916
-8,152
-6,324
-7,266
Income tax expense
20.993
20.993
2.459
1.95
2.75
Income from continuing operations
-7,937
-7,937
-8,154
-6,326
-7,269
Net income
-7,937
-7,937
-8,154
-6,326
-7,269
Net income available to common shareholders
-7,937
-7,937
-8,154
-6,326
-7,269
Basic EPS
-0.43
-
-1.81
-2.32
-2.66
Diluted EPS
-0.43
-
-1.81
-2.32
-2.66
Basic average shares
8,516
-
4,499
2,728
2,728
Diluted average shares
8,516
-
4,499
2,728
2,728